# DEFENCATH
> **NDA214520** · New Drug Application · Sponsor: CORMEDIX · Approved 2023-11-15
## Drug
- **FDA Application Number:** NDA214520
- **Application type:** New Drug Application
- **Brand name:** DEFENCATH
- **Generic name:** TAUROLIDINE AND HEPARIN
- **Active ingredients:** HEPARIN SODIUM; TAUROLIDINE
- **Dosage form:** SOLUTION
- **Route:** N/A
- **Marketing status:** Prescription
- **Sponsor:** CORMEDIX
- **Manufacturer:** CorMedix Inc.
- **First approval:** 2023-11-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214520)
---
*MORVS · CC0 1.0*